STOK

Stoke Therapeutics (STOK)

Stoke Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:STOK

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/23	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/21	05 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/21	05 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/18	05 : 30	Business Wire	Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/18	05 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/18	05 : 12	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/07	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/06	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/06	20 : 00	Business Wire	Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates	NASDAQ:STOK	Stoke Therapeutics Inc
2024/04/29	21 : 00	Business Wire	Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer	NASDAQ:STOK	Stoke Therapeutics Inc
2024/04/17	21 : 00	Business Wire	Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer	NASDAQ:STOK	Stoke Therapeutics Inc
2024/04/05	05 : 30	Business Wire	Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/28	12 : 40	Business Wire	Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/27	05 : 07	Business Wire	Stoke Therapeutics Announces Proposed Public Offering	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/26	05 : 01	Business Wire	Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/26	05 : 01	Business Wire	Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/06	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/02	06 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/27	00 : 38	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/27	00 : 36	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/14	23 : 20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/06	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/02	06 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/18	06 : 30	Business Wire	Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/08	22 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/08	22 : 00	Business Wire	Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/05	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/05	06 : 30	Business Wire	Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/03	06 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc